Medical & Surgical Urology

Medical & Surgical Urology
Open Access

ISSN: 2168-9857

+44-77-2385-9429

Review Article - (2017) Volume 6, Issue 3

Nocturnal Enuresis in Children and Adolescent with Sickle cell Anemia

Fathelrahman Elawad Ahmed*
Alneelain University, Khartoum, Sudan
*Corresponding Author: Fathelrahman Elawad Ahmed, Assistant Professor of pediatrics, Alneelain University, Khartoum, Sudan, Tel: 00966543998590 Email:

Abstract

Children with sickle cell anemia (SCA) have a tendency to have nocturnal enuresis (NE) more than normal children with males being more affected than females. Mechanisms of NE that operate in normal children probably do so in children with SCA. Postulated causes of nocturnal enuresis in individuals with SCA include hyposthenuria causing nocturnal polyuria, reduced bladder capacity or nocturnal bladder overactivity, sleep disordered breathing and an increased arousal thresholds. The variation in the reported prevalence rate of NE in SCA is probably due to differences in definition criteria and methodology. This review will discuss the prevalence rate and postulated causes of NE in children with SCA.

<

Keywords: Sickle cell anemia; Nocturnal enuresis; Prevalence; Pathogensis; Hyposthenuria; Obstructive sleep apnea; Perodic limb movement syndrome; Restless leg syndrome; Vitamins

Introduction

Sickle cell anemia (SCA) is one of the most common genetic disorders characterized by single gene mutation, where glutamic acid is replaced by valine in the 6th position of the beta chain. This causes polymerization of hemoglobin S in low oxygen tension leading to episodic occlusion of microcirculation [1].

SCA is a worldwide disease that affects mainly African, black- American, Arabs and those of Asian ancestry [2]. Wetting the bed at night two or more times per week after age 5 years, for a period of at least 3 months is called nocturnal enuresis (NE) [3]. NE is classified into primary (never being dry) and secondary (was dry before) enuresis and divided further into monosymptomatic (without daytime symptoms) versus non-monosymptomatic (with daytime symptoms) enuresis.

Prevalence of Nocturnal Enuresis in SCA

The first report on the prevalence rate of NE in SCA was in 1967 by Suster and Oski who reported a prevalence rate of 68.9% [4]. In 2014 Wolf and colleagues in a review article estimated the prevalence rate of NE in children and adolescent with SCA to range from 9-51% and that was derived from 10 relevant studies [5]. In this review 21 articles that reported the prevalence rate of NE in children and young adults with SCA were retrieved after thorough literature search (Table 1A-1C) [4,6-25]. We categorized these articles in 3 groups according to the criteria used to define NE.

Study/year Study design No(age range) Prevalence% Prevalance males/females (%) Primary NE% Secondary NE
Barakat et al. [6] Prospective structured phone interview. USA 217(5-22)
Hb SS
20 28.1/11% -----  
Jordan et al. [7] Prospective interview+symptoms check list. USA 126 (5–17)
Hb SS   
25 Not reported    
Ekinci et al. [8] Prospective questionnaire (Turkey) 55 (Hb SS (6–40) 9.1% Not reported ----  
Chakravorty S et al. [9] Cross-sectional,
questionnare base interview
UK
43(HbSS)
AGE:6-17 yrs
(30.2%)     37.9/33.3%              
Eneh et al. [10] Prospective cross-sectional descriptive 70(5-11)
Hb SS
31.4 48.7%/9.7%(p<0.0001 Not determined  
Ahmed et al. [11] Prospective cross-sectional(Sudan 78(5-16)
Hb SS
37.9 64% with ne were males 84.8 15.2
Eneh et al. [12] Prospective 70(8.37 ± 2.02)
Hb SS
31.4 48.7/23.1 Not determined  

Table 1a: Studies that used DSM-1V criteria to define nocturnal enuresis.

Study/year Study design No(age range) Prevalence% Prevalance males/females (%) Primary NE% Secondary NE
Readett et al. [13]*   175
(Hb SS)  
45.1% 15.1% 52/38%(NS)    
Figueroa et al. [14]* Prospective screening questionnaire (USA 91 (6–21)
HB SS, HB ßS
30% Not reported    
Ogunrinde et al. [15]** Structured questionnaire 360(5-17)
HB SS
41.7 46.7/36.4 75.5  

*- Studies that used frequency definition; **- Studies that used duration definition.

Table 1b: Studies that used incomplete DSM-IV criteria for definition of nocturnal enuresis.

Study/year Study design No(age range)
/genotype
Prevalence% Prevalence males/females (%) Primary NE% Secondary NE
Suster et al. [4] Parents interview 29(4-12)
Hb SS
68.9 Not reported    
Akinyanju et al. [16] Parental interview. Nigeria 206(4-20) 36.8 2.6:1    
Mabiala, et al [17]   Cross sectional 456 (5-20)
Hb SS
50.9 Common in females    
Field J et al [18] Prospective infants cohort 213(6-20)
Hb SS
33 % Not reported Not determined Not determined
Portocarrero et al. [19] Prospective 155(5-17)
Hb SS
32.2 39%/20% 86% 14%
Lehman et al. [20] Prospective 221(4-19)
Hb SS
39.9 48.6%/29.4%    
Mbong et al. [21]  Case control 45(2-17)
Hb SS
56.8 54.5/21.7    
Rosen CL [22] Prospective 243(4-18)
231 Hb S
12 HbSß0
30% - Not determined Not determined
 Al-Otaibi T [23] prospective 65(2-14)
HB SS
46% - - -
Daniel LC [24] prospective cross-section 54(4-10)
Hb SS
37%      
Jane S. Hankins [25]   100(2-18)
Hb SS
24      

Table 1c: Studies that used other definitions.

Group 1(Table 1a): Studies (total 7) that used Diagnostic and Statistical Manual of Mental Disorders, Fourth edition (DSM-IV) criteria for the diagnosis of NE.

Barakat et al. [6] studied 217 patients 5-22 years old and NE was reported to be present in 20% of them [6]. Ekinci et al. [8] from Turkey studied a mixed population of thalassemia and sickle cell anemia 6-40 years old. Out of 55 patients with sickle cell anemia only 5 patients (9.1%) were enuretic and they were children 11.0 ± 2.82 years old [8].

The remaining 5 studies included children whose ages were 5-17 years old, with a variation in age range, reported a prevalence rate of 25-37.9% [7,9-12].

Group 2(Table 1b): A prevalence rate of 30-45.2% was reported by the studies that used incomplete DSM-IV criteria to define NE [13-15].

Group 3(Table 1c): These are the studies that used different diagnostic criteria, they reported a prevalence rate of 32.2%-68.9% [4,16-25].

Primary nocturnal enuresis was the comments reported type, it occurred in 75.5-86% of patients [11,15,19]. This is similar to what had been reported in normal children with NE [26-28]. Only two studies further divided NE into monosymptomatic (MNE) and nonmonosymptomatic(NMNE) [9,19]. MNE was reported in 42-48.2% and NMNE was present in 51.8%-58% of children with NE.

The prevalence rate of NE in children with SCA decreases with increasing age from 29.7% at age 4-8 years to 9% at age 18-20 years (Figure 1) [6,9,10,12,16,17,19,20]. A similar trend was also observed in enuretic normal children [26-30].

medical-surgical-urology-NE-according-age

Figure 1: Prevalance of NE according to age.

The effect of gender on the prevalence rate of NE was reported by 12 studies. Boys were reported by 10 studies to have higher prevalence rate than girls [6,9-12,15,16,19-21], equal rates in both sexes was reported by one study [13] and one study reported a higher rate in females [17]. These findings are similar to those reported in normal children with NE [28,30-35]. According to Bottomley et al. [36] NE in normal children is twice more common in boys than girls up to the age of nine years, but thereafter there is no gender difference in prevalence [36]. No such observation was reported in children with SCA.

Enuresis in SCA: the postulated etiology

Wolf et al. in their review suggested that NE in SCA may be due to etiopathological factors that cause enuresis in normal children, SCArelated factors or a combination of both [4] The contribution of each of these factors in the causation of NE is not yet known.

The role of hyposthenuria in SCA-related nocturnal enuresis

The occurrence of hyposthenuria in patients with sickle cell anemia has been noted since 1928 [37]. Old studies had shown that all patients with SCA and about 70% of patients with sickle cell trait (SCT) have failure to maximally concentrate urine irrespective of age [38,39]. In two third of patients with SCT the defect in maximum urine concentration was similar to that seen in those with SCA [38]. The maximum urinary concentration declines with age in SCA and SCT [39]. Subsequent studies, using urine specific gravity or urine osmolality, demonstrated hyposthenuria in SCA and SCT as well [40-42].

The first study that linked hyposthenuria and nocturnal enuresis was in 1967 by Noll et al. [43]. This assumption was based on the fact that failure to concentrate urine is one of the earliest infarction- related renal complication of SCA [44]. Hyposthenuria, was therefore plausibly thought to manifest as polyuria and enuresis [45-47]. Subsequent studies did not support this assumption.

Readett et al. in 1990 investigated 16 enuretic and 16 age and sex matched non-enuretic children with SCA. There was no significant difference in maximum urine osmolality or urine volumes in the two groups following an overnight fluid deprivation tests N [48]. Ahmed et al. [11] in 2016 studied 87 children with SCA, 53 children with sickle cell trait and 50 normal children as a control. The mean urine specific gravity (USG) was within the normal range in the three groups. Furthermore, the mean urine specific gravity was 1.025 in sickle cell anemia patients with enuresis compared to a mean urine specific gravity of 1.027 in the sickle cell anemia patients without enuresis (P o. 15). In addition to that the prevalence rate of NE in children with sickle cell trait was not different from the control group (13.2% vs. 12.0% P 0.61). Eneh et al. in 2017 [12] studied 70 children with SCA and 70 children as control. The mean USG was significantly higher in the study group than in the control (1.02 ± 0.01 vs. 1.01 ± 0.01, P 0.018) Hyposthenuria was present in 4.5% of enuretic children with SCA compared to 8.3% of nonenuretic SCA patients. Furthermore they found that the mean USG was significantly higher in enuretic children with SCA compared to enuretic control (1.02 ± 0.01 vs. 1.01 ± 0.01, P 0.0107). How many children developed enuresis among those with hyposthenuria in both groups was not determined [12].

Figueroa et al. treated 10 children with SCA and enuresis with intranasal desmopressin acetate, 4 patients showed complete response and partial response was observed in other 2 patients [49]. Although the number of patients was small, the response rate to treatment is comparable to that seen in normal children treated with desmopressin for nocturnal enuresis [50]. From what had been mentioned above hposthenuria does not appear to be the root cause on NE in patients with SCA. In addition these findings support the concept that NE in SCA, although the prevalence is increased, has causes and treatment similar to normal children [60].

The urinary bladder and nocturnal enuresis

In children with SCA the maximum functional bladder capacity was found to be significantly decreased in enuretic children compared to nonenuric group and the ratio of overnight urine volume to maximum functional bladder capacity was significantly increased. Thus nocturnal enuresis was attributed to diminished bladder capacity [48].

Strong association between NE and urinary bladder dysfunction (UBD) was reported in children and adults with SCA [6,14,19,47,48,51,52]. Enuresis and nocturia, as indicators of UBD, are common in individuals with sickle cell anemia [18,43,53,54]. Field et al. reported that enuresis declined with age but nocturia persisted throughout childhood and early adulthood [18]. They attributed the reduction of NE despite the persistence of nocturia to improvement of sleep arousal in those patients. An increase in the maximum functional bladder capacity with age could be another possible explanation [50-55]. In a recent report, Claudino et al. [56] evaluated the urinary bladder function in a transgenic Sickle Cell Disease Mice. They found the following; reduced urine output, incapacity to produce typical bladder contraction and bladder emptying, lower detrusor muscle relaxation, small bladder contraction and reduced urethral contraction. Histologically there was reduction in detrusor muscle thickness and bladder volume in addition to chronic inflammatory cells infiltrates. They attributed these findings to chronic bladder ischemia resulting from repeated cycles of ischemia-reperfusion injury caused by SCA vasocclusion. The authors stated that the atonic detrusor muscle causes an underactive bladder with impaired bladder emptying and the reduction in the contractile response of the urethra leads to impaired continence which may contribute to enuresis observed in patients with SCA.

NE and Sleep-related disorders in SCA

These are conditions that cause poor quality or insufficient amount of sleep. They include among others sleep- disordered breathing (SDB) {like obstructive sleep apnea (OSA)}, restless legs syndrome (RLS) and periodic limb movement syndrome (PLMS) [25].

Night waking and sleep-disordered breathing was commoner in children with SCA than the control [25]. Obstructive sleep apnea (OSA) is the commonest of these disorders [57]. Few studies have described sleep-disordered breathing and OSA in children and adolescent with SCA using polysomnography(PSG) [23,58-62]. OSA was reported in 10-80% of children with Sickle cell disease [58-62,23]. A prevalence rate of 0.7-3% was reported in normal children [63].

NE and upper airway obstruction are they related?

A high prevalence rate of NE was found in normal children with upper airway obstruction [64-66]. A prevalence rate of 8-47% of NE was reported by some studies [66-70] in comparison to a prevalence rate of 2-15% in children without upper airway obstruction [71-74]. A high resolution rate of childhood nocturnal enuresis has been associated with tonsillectomy and/or adenotonsillectomy [64,66,75-83]. Moreover, nocturnal enuresis resolved in two children with mild obstructive SDB following administration of nasal corticosteroids [84]. Mbong et al. [21] reported a prevalence rate of NE of 100% in children with SCA and OSA compared to 46.2% in those without OSA (P 0.004). In a recent study from Saudi Arabia NE was reported in 62% of children with SCA and Obstructive apneahypoapnea index (OAHI) ≥ 1 compared to an overall prevalence rate of 46% [23]. Lehman and colleagues demonstrated in their study that habitual snoring and SDB with and without habitual snoring are associated with enuresis in children with SCA. The presence of enuresis, after adjusting for age and gender, was associated with OAHI ≥ 2 (OR 2.19; 95% CI 1.09, 4.40; p=0.03). After adjusting for age and gender, the association of habitual snoring alone and severe enuresis (≥ 3 wetting per night) among children with SCA was statistically significant (OR 1.83; 95% CI 1.02, 3.29; p=0.043) [20]. The authors suggested that in an enuretic child with SCA and snoring with adenotonsillar hypertrophy a formal sleep test should be performed; if SDB is detected then adenotonsillectomy would be the next line of therapy as recommended by the American academy of pediatrics [85]. The effect of tonsillectomy and/or adenotonsillectomy on NE in children with SCA and OSA was not studied.

Why does enuresis increase in children with OSA?

Among other factors [86-90] an increased bladder pressure as a result of increased abdominal pressure that occurs when breathing against an obstructed airway was suggested as a pathogenesis of NE. The increased bladder pressure in addition to the reduced urethral contraction that was observed in the transgenic Sickle Cell Disease Mice [56] could explain the increased frequency of NE in children with SCA and OSA.

Periodic limb movement syndrome (PLMS) and restless leg syndrome

Periodic limb movements are repetitive, highly stereotyped movements of the arms or legs occurring during sleep [91]. It is not commonly studied in children with SCA. It was reported in few studies to occur in 20.5-29% of children with SCA [25,59,93], a prevalence significantly higher than a 1.2-8% rate reported in healthy children [92-95]. RLS was reported in 11.1 of patients with SCA [25]. 12% of children with SCA who had PLMS had RLS [93]. Both PLMS and RLS were associated with sleep disruption [93]. Dhondt et al. studied 67 normal children with NE and 67 as a control for PLMS. Children with NE were found to have higher incidence of periodic limb movement and sleep fragmentation [96]. An increased occurrence of night waking and enuresis was observed in children with SCA [24]. Since patients with SCA have higher rate of PLMS which is associated with NE and sleep disruption we expect these children to have a high prevalence rate of NE. Research in this area is needed.

Brain maturation and nocturnal enuresis in SCA

Disorder of maturation of the brain, lack of arousal and a deficit in inhibition of micturition reflex have been considered to be the main abnormality leading to nocturnal enuresis in normal children. The markers reported to indicate cortical and brain stem immaturity were the presence of delayed bone age [97,98] slower motor performance [99] and reduced activation during motor response inhibition in children with PNE. Using functional magnetic resonance imaging (fMRI) of the brain, a relative lack of or delay in the maturation of prefrontal cortex circuitry, known to suppress inappropriate responses, was demonstrated by one study [100]. Another marker was the microstructural changes that were found in the brains of children with monosymptomatic NE. These abnormalities were located in the thalamus, frontal lobe, anterior cingulate cortex and insula [101]. Adults patients with schizophrenia who had NE in their childhood were found to have significant reduction in the brain gray matter involving the frontal and parietal lobes [102]. Further evidences were derived from neurophysiological studies [103-105]. The anatomical and physiological abnormalities were observed in areas which are involved in arousal and micturition control. There are no similar neurophysiological studies in children with SCA and NE but there was one study that used electroencephalogram (EEG) in subjects with SCA and showed generalized slow wave activity and that was suggested to be partly due to delayed brain maturity [106]. Various brain injuries were described in children with SCA. A significant reduction of the grey matter involving the cortex, thalamus and caudate nucleus was reported [107]. Using a quantitative MRI increased T1 was observed in the thalamus, frontal white matter, genu, and occipital white matter[108] Regional cortical thinning particularly involving the precuneus and the posterior cingulate was described [109]. This regional cortical thinning was found to be associated with reduced cerebrovascular reserve especially in areas with high metabolic activity (anterior cingulate, posterior cingulate, occipital gyrus, precuneus) [110]. Microstructural abnormalities of cerebral cortex, frontal white matter, centrum semiovale, periventricular areas, head of the caudate nSucleus, thalamus, brainstem, and pons were demonstrated by Balci et al. using quantitative brain diffusion-tensor MRI [111]. A progressive loss of brain volume [112] and volumetric growth delay of the brain gray matter was also demonstrated in these children [113]. Ischemia and/or infarction especially of the thalamus and basal ganglia were also described [114,115].

The micturition control network is widely spread in the brain. In their review article of published reports of brain imaging relevant to normal urine storage Griffith et al. found that sensation of urine storage is mapped in the insula; the anterior cingulate gyrus provides monitoring and control; the prefrontal cortex (PFC) makes voiding decision [116]. PFC was found to be under activated in normal children with primary NE, a finding suggestive of its immaturity [100]. The areas responsible of micturition control are part of the injured areas in patients with SCA and that might affect all aspects of micturition predisposing these children to NE among other voiding dysfunction.

It is interesting to note that children and adolescent with attentiondeficit/ hyperactivity disorder (ADHD), like those with SCA, have shown significant reduction in brain volume, gray matter volume and cortical thickness [117]. ADHD which is strongly associated with NE [118] was reported to occur in 19-25% of children with SCA [119].

Nocturnal enuresis and vitamins

Vitamin B12 and folate levels were reported to be low in normal children with primary nocturnal enuresis. Altunoluk et al. studied 30 children with Primary nocturnal enuresis, their mean serum B12 level were significantly lower compared to the control group; 30% of enuretic patients were found to have vitamin B12 deficiency but none of the control group [120]. Another study from Pakistan had shown lower level of serum B12 and folate in children with enuresis compared to non-enuretic children but none of the patients were deficient [121]. The authors suggested that this association might be due to delayed maturation of the brain as a result of low level of these vitamins.

Low level of vitamin B12 was reported in patients with SCA. Al- Momen reported vitamin B12 deficiency in 43.5% of patients with SCA age 14-49 years [122]. In Sudanese children with SCA age 6 months-15 years Vitamin B12 level was found to be significantly lower than the control and 7.1% were found to be deficient [123]. Similar results were reported by other studies [124-127]. 15% of children with sickle cell anemia had low serum folate despite adequate supplementation [127].

Wide spread microstructural changes in the cerebral white matter [128] and an altered cerebral blood flow [129] was demonstrated in adults with vitamin B12 deficiency. The altered cerebral blood flow was reversed with vitamin B12 treatment [129]. The effects of vitamin B12 on the brain are suggested to be mediated by the altered methylation reaction [130]. The current literature suggested a relationship between vitamin B12 and gray matter damage. People with good intake of vitamin B12 have a greater volume in the left and right superior parietal sulcus [131] and B-vitamin treatment markedly reduces gray matter atrophy in certain areas in the brain [132]. There are no studies that report vitamin B12 level in children with SCA and NE. Also there are no studies that looked at the brain microstructure of children with low level of vitamin B12. Studies are required to explore this area.

Vitamin D

Defining deficiency as vitamin D<20 ng/ ml, low 25-hydroxy [25 (OH)] vitamin D was found to be associated with an increased risk of NE in children aged five to seven years. Furtheremore, the severity of NE increases as the level of 25(OH) D decreases [133]. Using the same definition in a systematic analysis, the prevalence of vitamin D deficiency was reported to range from 56.4to 96.4% in children with SCA [134]. The association between vitamin D deficiency and NE can be explained partly by its influence on SDB and nocturnal polyuria.

Defining deficiency as vitamin D<20 ng/ ml, low 25-hydroxy [25 (OH)] vitamin D was found to be associated with an increased risk of NE in children aged five to seven years. Furtheremore, the severity of NE increases as the level of 25(OH) D decreases [133]. Using the same definition in a systematic analysis, the prevalence of vitamin D deficiency was reported to range from 56.4to 96.4% in children with SCA [134]. The association between vitamin D deficiency and NE can be explained partly by its influence on SDB and nocturnal polyuria.

Restless leg syndrome (RLS), another SDB, was found to be more frequent and more severe in in adults with vitamin D deficiency [140-142] and it has a negative effect on sleep parameters [8]. Vitamin D supplementation was found to improve the severity of RLS [143]. The association of OSAS and RLS with NE in children with SCA was discussed earlier.

Vitamin D receptors were reported to be present in the brain in areas that have an important role in initiation and maintenance of sleep [144]. Moreover significant improvement in sleep quality was observed with vitamin D supplementation [145]. Vitamin D deficiency in children and an adolescent with SCA was associated with painful crisis [146]. Pain literature had shown than nocturnal pain disturbed sleep [147]. A subjective sleepiness can accompany the relative elevation of the levels of inflammatory mediators as part of immune dysregulation that is proposed to occur with low 25(OH) D [148]. Children with NE were observed to suffer from sleep fragmentation [149] Therefore, it is plausible to assume that low vitamin D is associated with poor sleep quality including sleep fragmentation in children with SCA that leads to NE.

Vitamin D receptor knockout mice that had normal renal function were observed to develop polyuria, as a result of increased water intake [150]. The latter was due to renin up regulation leading to an increased production of angiotensin II [151]. In another study, using similar mice, reduction of renin-angiotensin activity in paraventricular nucleus with inhibition of thirst was achieved following vitamin D analogs injection. The authors concluded that polydipsia and polyuria may be caused by a lack of vitamin D [150]. Nocturnal polyuria had been reported in normal children [152,153] and children with SCA who had NE and was considered a pathogenic factor [18,41,51,52]. In conclusion low vitamin D level may lead to NE through OSA, sleep fragmentation and nocturnal polyuria.

Cortical arousal and NE in SCA

Impaired cortical arousal, as determined by known EEG parameters, is a probable risk factor for NE. Children with NE were considered deep sleepers [154]. There are conflicting data regarding the pattern of sleep in children with NE [155,156]. Frequent cortical arousal with inability to awaken completely was observed in children with severe refractory NE [157]. Pattern of cortical arousal has not yet been assessed in children with SCA and NE. Sleep architecture of children and adolescent with SCA was found to be similar to that of normal children [158]. High rates of SDB and night waking was reported in children with SCA [159]. Sleep fragmentation is a common features in children with SCA and PLMS and RLS [93,96]. Thus repeated cortical arousal might be common in SCA and NE . Studies are needed to explore this area.

Conclusion

NE is prevalent in children with SCA; it occurred in 25-37.9% 0f them according to DSM-IV criteria. Males are commonly affected. Primaty NE is the commonest type. Nocturnal and diurnal enuresis occurs at almost equal rates. NE is likely to be due to multiple causes. Sleep-related disorder is associated with increased prevalence of enuresis. Hyposthenuria is not the root cause of NE. Low levels of cobalamine and vitamin D are theoretically probable modifiable cause of NE. Further studies are needed to explore this area.

References

  1. Bunn HF (1997) Pathogenesis and treatment of sickle cell disease. N Engl J Med 337: 762-769.
  2. Adegoke SA, Abioye-Kuteyi EA, Orji EO (2014) The rate and cost of hospitalisation in children with sickle cell anaemia and its implications in a developing economy. Afr Health Sci 14: 475-480.
  3. American Psychiatric Association, Task Force on DSM-IV (2000) Diagnostic and statistical manual of mental disorders: DSM-IV-TR. American Psychiatric Association; Washington, DC, USA.
  4. Suster G, Oski FA (1967) Enuresis in Sickle Cell Anemia. Am J Dis Child:113: 311.
  5. Wolf RB, Kassim AA, Goodpaster RL, DeBaun MR (2014) Nocturnal enuresis in sickle cell disease. Expert Rev Hematol 7: 245-254.
  6. Barakat LP, Smith-Whitley K, Schulman S, Rosenberg D, Puri R, et al. (2001) Nocturnal enuresis in pediatric sickle cell disease. J Dev Behav Pediatr 22: 300-305.
  7. Jordan SS, Hilker KA, Stoppelbein L, Elkin TD, Applegate H, et al. (2005) Nocturnal enuresis and psychosocial problems in pediatric sickle cell disease and sibling controls. J Dev Behav Pediatr 26: 404-411.
  8. Ekinci O, Celik T, Ünal S, Oktay G, Toros F (2013) Nocturnal enuresis in sickle cell disease and thalassemia major: associated factors in a clinical sample. Int J Hematol: 98: 430-436.
  9. Chakravorty S, Josu de la F, Ali M (2013) Prevalence of Nocturnal Enuresis and Proteinuria In Children With Sickle Cell Disease and Its Relation To Severity Of Painful Crises. Blood 122: 4693.
  10. Eneh CI, Okafor HU, Ikefuna AN, Uwaezuoke SN (2015) Nocturnal enuresis: prevalence and risk factors among school-aged children with sickle-cell anaemia in a South-east Nigerian city. Ital J Pediatr 41: 66.
  11. Ahmed FE, Salim E, Salih K (2016) Nocturnal enuresis among Sudanese children with sickle cell anemia. Curr Pediatr Res: 20: 294-233.
  12. Eneh CI, Ikefuna AN, Okafor HU, Uwaezuoke SN2 (2017) Nocturnal enuresis in school-aged children with sickle-cell anemia: Any relationship with hyposthenuria? Niger J Clin Pract 20: 215-220.
  13. Readett DR, Morris JS, Serjeant GR (1990) Nocturnal enuresis in sickle cell haemoglobinopathies. Arch Dis Child 65: 290-293.
  14. Figueroa TE, Benaim E, Griggs ST, Hvizdala EV (1995) Enuresis in sickle cell disease. J Urol 153: 1987-1989.
  15. Ogunrinde GO, Zubair RO, Mado SM, Umar LW (2007) Prevalence of nocturnal enuresis in children with homozygous sickle-cell disease in Zaria. Nig J Paediatr: 34: 31-35
  16. Akinyanju O, Agbato O, Ogunmekan AO, Okoye JU (1989) Enuresis in sickle cell disease. I. Prevalence studies. J Trop Pediatr 35: 24-26.
  17. Mabiala Babela JR, Loumingou R, Pemba-Loufoua A, Londjongo W, Nzingoula S, et al. (2004) Enuresis in children with sickle cell disease]. Arch Pediatr 11: 1168-1172.
  18. Field JJ, Austin PF, An P, Yan Y, DeBaun MR (2008) Enuresis is a common and persistent problem among children and young adults with sickle cell anemia. Urology 72: 81-84.
  19. Portocarrero ML, Portocarrero ML, Sobral MM, Lyra I, Lordêlo P, et al. (2012) Prevalence of enuresis and daytime urinary incontinence in children and adolescents with sickle cell disease. J Urol 187: 1037-1040.
  20. Lehmann GC, Bell TR, Kirkham FJ, Gavlak JC, Ferguson TF, et al. (2012) Enuresis associated with sleep disordered breathing in children with sickle cell anemia. J Urol 188: 1572-1576.
  21. Mbong L, Ngarka ET, Chokote LN, Njoh JY (2013) Bedwetting and sleep disorders in sickle cell disease patients in Cameroon. J Neurol Sci 333: e717.
  22. Rosen CL, Debaun MR, Strunk RC, Redline S, Seicean S, et al. (2014) Obstructive sleep apnea and sickle cell anemia. Pediatrics 134: 273-281.
  23. Al-Otaibi T, Al-Qwaiee M, Faraidi H, Batniji F, Al-Otaibi F, et al. (2017) Prevalence of obstructive sleep apnea in children with sickle cell disease at a tertiary hospital in Saudi Arabia. Saudi Med J 38: 616-620.
  24. Daniel LC, Grant M, Kothare SV, Dampier C, Barakat LP (2010) Sleep patterns in pediatric sickle cell disease. Pediatr Blood Cancer 55: 501-507.
  25. Hankins JS, Verevkina NI, Smeltzer MP, Wu S, Aygun B, et al. (2014) Assessment of sleep-related disorders in children with sickle cell disease. Hemoglobin 38: 244-251.
  26. [No authors listed] (2016) Corrigendum to "The complete mitochondrial genome of the gnomefish Scombrops boops (Teleostei, Perciformes, Scombropidae) from the Pacific Ocean off the Japanese Islands" Mitochondrial DNA A DNA Mapp Seq Anal 27: 2825.
  27. Ropper AH, Samuels MA (2009) Sleep and Its Abnormalities. Adams and Victor’s Principles of Neurology. 9th (Edn), New York, USA.
  28. Salih K, Ahmed FE, Omer YI, Salih A, Elnour W, et al. (2013) Characteristics and etiological factors of nocturnal enuresis in Sudanese Children. Am J Med Den Sci 1: 40-45.
  29. Lee SD, Sohn DW, Lee JZ, Park NC, Chung MK (2000) An epidemiological study of enuresis in Korean children. BJU Int 85: 869-873.
  30. Gümüş B, Vurgun N, Lekili M, Işcan A, Müezzinoğlu T, et al. (1999) Prevalence of nocturnal enuresis and accompanying factors in children aged 7-11 years in Turkey. Acta Paediatr 88: 1369-1372.
  31. Gur E, Turban P, Can G, Akkus S(2004) Enuresis: Prevalence, risk factors and urinary pathology among school children in Istanbul, Turkey. Pediatr Int 46: 58-63.
  32. Cher TW, Lin GJ, Hsu KH (2002) Prevalence of nocturnal enuresis and associated familial factors in primary school children in taiwan. J Urol 168: 1142-1146.
  33. Oge O, Kocak I, Gemalmaz H (2010) Enuresis: Point prevalence and associated factors among: Turkish children. Turk J Pediatr 43: 38-43.
  34. Cher TW, Lin GJ, Hsu KH (2002) Prevalence of nocturnal enuresis and associated familial factors in primary school children in taiwan. J Urol 168: 1142-1146.
  35. Mithani S, Zaidi Z (2005) Bed wetting in school children of Karachi. J Pak Med Assoc 55: 2-5.
  36. Bottomley G (2011) Treating nocturnal enuresis in children in primary care. Practitioner 255: 23-26.
  37. Josephs H (1928) clinical aspect of sickle cell anemia. Bull. John Hopkins hospital 43: 397.
  38. Itano HA, Keitel HG, Thompson D (1956) Hyposthenuria in sickle cell anemia: a reversible renal defect. J Clin Invest 35: 998-1007.
  39. Francis YF, Worthen HG (1968) Hyposthenuria in sickle cell disease. J Natl Med Assoc 60: 266-270.
  40. Ugwu RO, Eke FU (2007) Urinary abnormalities in children with sickle cell anaemia. Port Harcourt Med J 2: 45-50
  41. Kaze F, Kengne A, Atanga L, Lobe M, Menanga A, et al. (2013) Kidney function, urinalysis abnormalities and correlates in equatorial Africans with sickle cell disease. Clin Kidney J 6: 15-20.
  42. Sesso R, Almeida MA, Figueiredo MS, Bordin JO (1998) Renal dysfunction in patients with sickle cell anemia or sickle cell trait. Braz J Med Biol Res 31: 1257-1262.
  43. Reid CD, Renals I, Bertnam L, Reid CD, Charache C, et al. (editors) (1995) Management and therapy of Sickle cell disease. 3rd (Edn), NIH Publication, Maryland pp: 95-100.
  44. Embury SH, Hebbel RP, Steinberg MH, Mohandas N (1995) Pathogenesis of vaso-occlusion. In: Sickle cell disease. Basic principles and clinical practice.1st (Edn), Lippincott-raven, Philadelphia pp: 311-326.
  45. Becker AM (2011) Sickle cell nephropathy: challenging the conventional wisdom. Pediatr Nephrol 26: 2099-2109.
  46. Claudino MA, Fertrin KY (2012) Sickling cells, cyclic nucleotides, and protein kinases: the pathophysiology of urogenital disorders in sickle cell anemia. Anemia 2012: 723520.
  47. Readett DR, Morris J, Serjeant GR (1990) Determinants of nocturnal enuresis in homozygous sickle cell disease. Arch Dis Child 65: 615-618.
  48. Figueroa TE, Benaim E, Griggs ST, Hvizdala EV (1995) Enuresis in sickle cell disease. J Urol 153: 1987-1989.
  49. Anele UA, Morrison BF, Reid ME, Madden W, Foster S, et al. (2016) Overactive bladder in adults with sickle cell disease. Neurourol Urodyn 35: 642-646.
  50. Silva IV, Reis AF, Palaré MJ, Ferrão A, Rodrigues T, et al. (2015) Sickle cell disease in children: chronic complications and search of predictive factors for adverse outcomes. Eur J Haematol 94: 157-161.
  51. Noll JB, Newman AJ, Gross S (1967) Enuresis and nocturia in sickle cell disease. J Pediatr 70: 965-967.
  52. Kwak KJ, Scott RB, Ferguson AD (1969) Studies in sickle-cell anemia. XXXIV. Observations on enuresis in childhood and nocturia in adults. Clin Pediatr (Phila) 8: 344-346.
  53. Korzeniecka-Kozerska A, Zoch-Zwierz W, Wasilewska A(2005) Functional bladder capacity and urine osmolality in children with primary monosymptomatic nocturnal enuresis. Scand J Urol Nephrol 39: 56-61.
  54. Claudino MA, Leiria LO, da Silva FH, Alexandre EC, Renno A, et al. (2015) Urinary Bladder Dysfunction in Transgenic Sickle Cell Disease Mice. PLoS One 10: e0133996.
  55. National Heart Lung and Blood Institute (2003) National Sleep Disorders Research Plan, National Institutes of Health, Bethesda.
  56. Kaleyias J, Mostofi N, Grant M, Coleman C, Luck L, et al. (2008) Severity of obstructive sleep apnea in children with sickle cell disease. J Pediatr Hematol Oncol 30: 659-665.
  57. Rogers VE, Lewin DS, Winnie GB, Gieger-Brown J (2010) Polysomnographic charateristics of a referred sample of children with sickle cell disease. J Clin Sleep Med 6: 374-381.
  58. Samuels MP, Stebbens VA, Davies SC, Picton-Jones E, Southall DP (1992) Sleep related upper airway obstruction and hypoxaemia in sickle cell disease. Arch Dis Child 67: 925-929.
  59. Salles C, Ramos RT, Daltro C, Barral A, Marinho JM, et al. (2009) Prevalence of obstructive sleep apnea in children and adolescents with sickle cell anemia. J Bras Pneumol 35: 1075-1083.
  60. Goldstein NA, Keller R, Rey K, Rao S, Weedon J, et al. (2011) Sleep-disordered breathing and transcranial Dopplers in sickle cell disease. Arch Otolaryngol Head Neck Surg 137: 1263-1268.
  61. Brunetti L, Rana S, Lospalluti ML, Pietrafesa A, Francavilla R, et al. (2001) Prevalence of obstructive sleep apnea syndrome in a cohort of 1,207 children of southern Italy. Chest 120: 1930-1935.
  62. Brooks LJ, Topol HI (2003) Enuresis in children with sleep apnea. J Pediatr 142: 515-518.
  63. Weider DJ, Sateia MJ, West RP (1991) Nocturnal enuresis in children with upper airway obstruction. Otolaryngol Head Neck Surg 105: 427-432.
  64. Stone J, Malone PS, Atwill D, McGrigor V, Hill CM (2008) Symptoms of sleep-disordered breathing in children with nocturnal enuresis. J Pediatr Urol 4: 197-202.
  65. Basha S, Bialowas C, Ende K, Szeremeta W (2005) Effectiveness of adenotonsillectomy in the resolution of nocturnal enuresis secondary to obstructive sleep apnea. Laryngoscope 115: 1101-1103.
  66. Wang RC, Elkins TP, Keech D, Wauquier A, Hubbard D (1998) Accuracy of clinical evaluation in pediatric obstructive sleep apnea. Otolaryngol Head Neck Surg 118: 69-73.
  67. Brouilette R, Hanson D, David R, Klemka L, Szatkowski A, et al. (1984) A diagnostic approach to suspected obstructive sleep apnea in children. J Pediatr 105: 10-14.
  68. Austin PF, Bauer SB, Bower W, Chase J, Franco I, et al. (2016). The standardization of terminology of lower urinary tract function in children and adolescents: Update report from the standardization committee of the International Children’s Continence Society. Neurourol Urodyn 35: 471-481.
  69. Butler RJ, Holland P (2000) The three systems: a conceptual way of understanding nocturnal enuresis. Scand J Urol Nephrol 34: 270-277.
  70. Hjalmas K, Arnold T, Bower W, Caione P, Chiozza LM, et al. (2004) Nocturnal enuresis: an international evidence based management strategy. J Urol 171: 2545-2561.
  71. Lee SD, Sohn DW, Lee JZ, Park NC, Chung MK (2000) An epidemiological study of enuresis in Korean children. BJU Int 85: 869-873.
  72. Firoozi F, Batniji R, Aslan AR, Longhurst PA, Kogan BA (2006) Resolution of diurnal incontinence and nocturnal enuresis after adenotonsillectomy in children. J Urol 175: 1885-1888.
  73. Basha S, Bialowas C, Ende K, Szeremeta W (2005) Effectiveness of adenotonsillectomy in the resolution of nocturnal enuresis secondary to obstructive sleep apnea. Laryngoscope 115: 1101-1103.
  74. Leiberman A, Stiller-Timor L, Tarasiuk A, Tal A (2006) The effect of adenotonsillectomy on children suffering from obstructive sleep apnea syndrome (OSAS): the Negev perspective. Int J Pediatr Otorhinolaryngol 70: 1675-1682.
  75. Weissbach A, Leiberman A, Tarasiuk A, Goldbart A, Tal A (2006)Adenotonsilectomy improves enuresis in children with obstructive sleep apnea syndrome. Int J Pediatr Otorhinolaryngol 70: 1351-1356.
  76. Kovacevic L, Jurewicz M, Dabaja A, Thomas R, Diaz M, et al. (2013)Enuretic children with obstructive sleep apnea syndrome: should they see otolaryngology first? J Pediatr Urol 9: 145-150
  77. Kovacevic L, Wolfe-Christensen C, Lu H, Toton M, Mirkovic J, et al. (2014) Why does adenotonsillectomy not correct enuresis in all children with sleep disordered breathing? See comment in PubMed Commons below J Urol 191: 1592-1596.
  78. Ahmadi MS, Amirhassani S, Poorolajal J (2013) The effect of adenotonsillectomy on pediatric nocturnal enuresis: a prospective cohort study. Iran J Otorhinolaryngol 25: 37-40.
  79. Jeyakumar A, Rahman SI, Armbrecht ES, Mitchell R (2012) The association between sleep-disordered breathing and enuresis in children. Laryngoscope 122: 1873-1877.
  80. Park S, Lee JM, Sim CS, Kim JG, Nam JG, et al. (2016) Impact of adenotonsillectomy on nocturnal enuresis in children with sleep-disordered breathing: A prospective study. Laryngoscope 126: 1241-1545.
  81. Alexopoulos EI, Kaditis AG, Kostadima E, Gourgoulianis K (2005) Resolution of nocturnal enuresis in snoring children after treatment with nasal budesonide. Urology 66: 194.
  82. Section on Pediatric Pulmonology (2002) Subcommittee on Obstructive Sleep Apnea Syndrome. American Academy of Pediatrics Clinical practice guideline diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics pp: 109-704.
  83. Nevéus T, Stenberg A, Läckgren G, Tuvemo T, Hetta J (1999) Sleep of children with enuresis: a polysomnographic study. Pediatrics 103: 1193-1197.
  84. Kaditis AG, Alexopoulos EI, Evangelopoulos K, Kostadima E, Varlami V, et al. (2010) Correlation of urinary excretion of sodium with severity of sleep-disordered breathing in children: a preliminary study. Pediatr Pulmonol 45: 999-1004.
  85. O’Driscoll DM, Foster AM, Davey MJ, Nixon GM, Horne RS (2010) Can actigraphy measure sleep fragmentation in children? Arch Dis Child 95: 1031-1033.
  86. Staessen JA, Birkenhäger W, Bulpitt CJ, Fagard R, Fletcher AE, et al. (1993)The relationship between blood pressure and sodium and potassium excretion during the day and at night. J Hypertens 11: 443-447.
  87. Zaffanello M, Piacentini G, Lippi G, Fanos V, Gasperi E, et al. (2017) Obstructive sleep-disordered breathing, enuresis and combined disorders in children: chance or related association? Swiss Med Wkly 6: 147.
  88. Arai H, Furuta H, Kosaka K, Kaneda R, Koshino Y, et al. (1999) Polysomnographic and urodynamic changes in a case of obstructive sleep apnea syndrome with enuresis. Psychiatry Clin Neurosci 53: 319-320.
  89. Khatwa U, Kothare SV (2010) Restless legs syndrome and periodic limb movements disorder in the pediatric population. Curr Opin Pulm Med 16: 559-567.
  90. Rogers VE, Marcus CL, Jawad AF, Smith-Whitley K, Ohene-Frempong K, et al. (2011) Periodic limb movements and disrupted sleep in children with sickle cell disease. Sleep 34: 899-908.
  91. Kirk VG, Bohn S (2004) Periodic limb movements in children: prevalence in a referred population. Sleep 27: 313-315.
  92. Traeger N, Schultz B, Pollock AN, Mason T, Marcus CL, et al. (2005) Polysomnographic values in children 2-9 years old: additional data and review of the literature. Pediatr Pulmonol 40: 22-30.
  93. Dhondt K, Baert E, Van Herzeele C, Raes A, Groen LA, et al. (2014) Sleep fragmentation and increased periodic limb movements are more common in children with nocturnal enuresis. Acta Paediatr 103: e268-272.
  94. Dhondt K, Van Herzeele C, Roels SP, Raes A, Groen LA, et al. (2015) Sleep fragmentation and periodic limb movements in children with monosymptomatic nocturnal enuresis and polyuria. Pediatric Nephrology 30: 1157-1162.
  95. Dundaroz MR, Sarici SU, Denli M, Aydin HI, Kocaoglu M, et al. (2001) Bone age in children with nocturnal enuresis. Int Urol Nephrol 32: 389-391.
  96. Mimouni M, Shuper A, Mimouni F, Grünebaum M, Varsano I (1985) Retarded skeletal maturation in children with primary enuresis. Eur J Pediatr 144: 234-235.
  97. von Gontard A, Freitag CM, Seifen S, Pukrop R, Röhling D (2006) Neuromotor development in nocturnal enuresis. Dev Med Child Neurol 48: 744-750.
  98. Lei D, Ma J, Du X, Shen G, Tian M, et al. (2012) Altered brain activation during response inhibition in children with primary nocturnal enuresis: an fMRI study. Hum Brain Mapp 33: 2913-2919.
  99. Lei D, Ma J, Shen X, Du X, Shen G, et al. (2012) Changes in the brain microstructure of children with primary monosymptomatic nocturnal enuresis: a diffusion tensor imaging study. PLoS One 7: e31023.
  100. Hyde TM, Deep-Soboslay A, Iglesias B, Callicott JH, Gold JM, et al. (2008) Enuresis as a premorbid developmental marker of schizophrenia. Brain 131: 2489-2498.
  101. Freitag CM, Röhling D, Seifen S, Pukrop R, Von Gontard A (2006) Neurophysiology of nocturnal enuresis: Evoked potentials and prepulse inhibition of the startle reflex. Dev Med Child Neurol 48: 78-84.
  102. Hallioglu O, Ozge A, Comelekoglu U, Topaloglu AK, Kanik A, et al. (2001) Evaluation of cerebral maturation by visual and quantitative analysis of resting Electroencephalography in children with primarynocturnal enuresis. J Child Neurol 16: 714-718.
  103. Hashem S, Salem S, El-Ghoneimy M, Mostafa S, Nada M, et al. (2005) Neurophysiological l Assessment of Patients with Primary Nocturnal Enuresis. J Neurol Psychiat Neurosurg 42: 301-309.
  104. Gott PS, Haywood LJ, Allen JP, Harvey GA, Powars DR, et al. (1977) Frequency analysis of the EEG in children with sickle cell disease. J Natl Med Assoc 69: 811-813.
  105. Steen RG, Langston JW, Ogg RJ, Xiong X, Ye Z, Wang WC (1999) Diffuse T1 reduction in gray matter of sickle cell disease patients: Evidence of selective vulnerability to damage? Magn Reson Imaging 17: 503-515.
  106. Steen RG, Langston JW, Reddick WE, Ogg R, Chen G, et al. (1996) Quantitative MR imaging of children with sickle cell disease: striking T1 elevation in the thalamus. J Magn Reson Imaging 6: 226-234.
  107. Kirk GR, Haynes MR, Palasis S, Brown C, Burns TG, et al. (2009) McCormick M, Jones RA. Regionally specific cortical thinning in children with sickle cell disease. Cereb Cortex 19: 1549-1556.
  108. Kim JA, Leung J, Lerch JP, Kassner A (2016) Reduced cerebrovascular reserve is regionally associated with cortical thickness reductions in children with sickle cell disease. Brain Res 1642: 263-269.
  109. Balci A, Karazincir S, Beyoglu Y, Cingiz C, Davran R, et al. (2012) Quantitative brain diffusion-tensor MRI findings in patients with sickle cell disease. AJR Am J Roentgenol 198: 1167-1174.
  110. Eigbire-MolenO, Darbari DS, Ponisio MR, Milchenko MV, Rodeghier MJ, et al. (2015) Progressive Loss of Brain Volume in Children with Sickle Cell Anemia: A Report from the Silent Cerebral Infarct Transfusion Trial Cohort. Blood 126: 546.
  111. Steen RG, Emudianughe T, Hunte M, Glass J, Wu S, et al. (2005) Brain volume in pediatric patients with sickle cell disease: evidence of volumetric growth delay. AJNR Am J Neuroradiol 26: 455-462.
  112. Moser FG, Miller ST, Bello JA, Pegelow CH, Zimmerman RA, et al. (1996) The spectrum of brain MR abnormalities in sickle-cell disease: a report from the Cooperative Study of Sickle Cell Disease. AJNR Am J Neuroradiol 17: 965-972.
  113. Kwiatkowski JL, Zimmerman RA, Pollock AN, Seto W, Smith-Whitley K, et al. (2009) Silent infarcts in young children with sickle cell disease. Br J Haematol 146: 300-305.
  114. Fowler CJ1, Griffiths DJ (2010) A decade of functional brain imaging applied to bladder control. Neurourol Urodyn 29: 49-55.
  115. Narr KL, Woods RP, Lin J, Kim J, Phillips OR, et al. (2009) Widespread cortical thinning is a robust anatomical marker for attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 48: 1014-1022.
  116. Shreeram S, He JP, Kalaydjian A, Brothers S, Merikangas KR (2009) Prevalence of Enuresis and Its Association with Attention-Deficit/Hyperactivity Disorder Among U.S. Children: Results From a Nationally Representative Study. J Am Acad Child Adolesc Psychiatry 48: 35-41.
  117. Acquazzino MA, Miller M, Myrvik M, Newby R, Scott JP (2017) Attention Deficit Hyperactivity Disorder in Children With Sickle Cell Disease Referred for an Evaluation. J ediatr Hematol Oncol 39: 350-354.
  118. Altunoluk B, Davutoglu M, Garipardic M, Bakan V (2012) Decreased vitamin B12 levels in children with nocturnal enuresis. ISRN Urol 789706.
  119. Albayrak S, Zengin K, Tanik S, Daar G, Ozdamar MY, et al. (2014) Vitamin B12, folate and iron levels in primary nocturnal enuresis. Pak J Med Sci 31: 87-90.
  120. Al-Momen AK (1995) Diminished vitamin B12 levels in patients with severe sickle cell disease. J Intern Med 237: 551-555.
  121. Ahmed I, Sir-Elfatouh A, Gaufri N (2016) Significant Reduction of Vitamin B12 Levels in Sudanese Sickle Cell Disease Patients. Open Access Library Journal 3: 1-7.
  122. Osifo BO, Lukanmbi FA, Adeyokunnu A (2009) Serum cobalamin concentration in sickle cell disease (HbSS). Acta Haematol 71: 299-303.
  123. Kamineni P, Chirla S, Dinh K, Hasan S, Nidhiry E, et al. (2006) Low Cobalamin Levels in African Americans with and without Sickle Cell Disease. J Natl Med Assoc 98: 352-356.
  124. Ajay OI, Bwayo-Weaver S, Chirla S, Serlemitsos-Day M, Daniel M, et al. (2013) Cobalamin Status in Sickle Cell Disease. International Journal of Laboratory Hematology 35: 31-37.
  125. Kennedy TS, Fung EB, Kawchak DA, Zemel BS, Ohene-Frempong K, et al. (2001) Red blood cell folate and serum vitamin B12 status in children with sickle cell disease. J Pediatr Hematol Oncol 23: 165-169.
  126. Gupta PK, Gupta RK, Garg RK, Rai Y, Roy B, et al (2014) DTI correlates of cognition in conventional MRI of normal-appearing brain in patients with clinical features of subacute combined degeneration and biochemically proven vitamin B 12 deficiency. AJNR Am J Neuroradiol 35: 872-877.
  127. Roy B, Trivedi R, Garg RK, Gupta PK, Tyagi R, et al. (2015) Assessment of functional and structural damage in brain parenchyma in patients with vitamin B12 deficiency: A longitudinal perfusion and diffusion tensor imaging study. Magn Reson Imaging 33: 537-543. Werder SF (2010) Cobalamin deficiency, hyperhomocysteinemia, and dementia. Europsychiatr Dis Treat 6: 159-195.
  128. Farrall AJ, Wardlaw JM (2009) Blood-brain barrier: ageing and microvascular disease--systematic review and meta-analysis. Neurobiol Aging 30: 337-352.
  129. Douaud G, Refsum H, de Jager CA, Jacoby R, Nichols TE, et al(2013) Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment. Proc Natl Acad Sci U S A 110: 9523-9528.
  130. Li L, Zhou H, Yang X, Zhao L, Yu X (2014) Relationships between 25-hydroxyvitamin D and nocturnal enuresis in five- to seven-year-old children. PLoS One 9: e99316.
  131. Nolan VG, Nottage KA, Cole EW, Hankins JS, Gurney JG (2015) Prevalence of vitamin D deficiency in sickle cell disease: a systematic review. PLoS One 10: e0119908.
  132. PLos One Staff (2015) Correction: prevalence of vitamin d deficiency in sickle cell disease: a systematic review. PLoS One 10: e0128853.
  133. Ozgurhan G, Vehapoglu A, Vermezoglu O, Temiz RN, Guney A, et al. (2016) Risk assessment of obstructive sleep apnea syndrome in pediatric patients with vitamin D deficiency: A questionnaire-based study. Medicine (Baltimore) 95: e4632
  134. Kheirandish-Gozal L, Peris E, Gozal D (2014) Vitamin D levels and obstructive sleep apnoea in children. Sleep Med 15: 459-463.
  135. Zicari AM, Occasi F, Di Mauro F, Lollobrigida V, Di Fraia M, et al. (2016) Mean Platelet Volume, Vitamin D and C Reactive Protein Levels in Normal Weight Children with Primary Snoring and Obstructive Sleep Apnea Syndrome. PLoS One 11: e0152497.
  136. Reid D, Morton R, Salkeld L, Bartley J (2011) Vitamin D and tonsil disease--preliminary observations. Int J Pediatr Otorhinolaryngol 75: 261-264
  137. McCarty DE, Chesson AL Jr, Jain SK, Marino AA (2014) The link between vitamin D metabolism and sleep medicine. Sleep Med Rev 18: 311-319.
  138.  Cakir T, Dogan G, Subaşi V, Filiz MB, Ulker N, et al. (2015) An evaluation of sleep quality and the prevalence of restless leg syndrome in vitamin D deficiency. Acta Neurol Belg 115: 623-627.
  139. Balaban H, Yildiz OK, Çil G, Şenturk IA, Erselcan T, et al. (2012) Serum 25-hydroxyvitamin D levels in restless legs syndrome patients. Sleep Med 13: 953-957.
  140. Oran M, Unsal C, Albayrak Y, Tulubas F, Oguz K, et al (2014) Possible association between vitamin D deficiency and restless legs syndrome. Neuropsychiatr Dis Treat 10: 953-958.
  141. Wali S, Shukr A, Boudal A, Alsaiari A, Krayem A (2015) The effect of vitamin D supplements on the severity of restless legs syndrome. Sleep Breath 19: 579-583.
  142. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ (2005) Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 29: 21-30.
  143. Gominak SC, Stumpf WE (2012) The world epidemic of sleep disorders is linked to vitamin D deficiency. Med Hypotheses 79: 132-135.
  144. De Oliveira JF, Vicente NG, Santos JP, Weffort VR (2015) [Vitamin D in children and adolescents with sickle cell disease: an integrative review]. Rev Paul Pediatr 33: 350-355.
  145. Onen SH, Onen F, Courpron P, Dubray C (2005) How pain and analgesics disturb sleep. Clin J Pain 21: 422-431.
  146. Krueger JM, Majde JA, Rector DM (2011) Cytokines in immune function and sleep regulation. Handb Clin Neurol 98: 229-240.
  147. Cohen-Zrubavel V, Kushnir B, Kushnir J, Sadeh A (2011) Sleep and sleepiness in children with nocturnal enuresis. Sleep 34: 191-194.
  148. Kong J, Zhang Z, Li D, Wong KE, Zhang Y, et al. (2008) Loss of vitamin D receptor produces polyuria by increasing thirst. J Am Soc Nephrol 19: 2396-2405.
  149. Fu Y, Sun C, Guo J, Zhao Q, Kong J (2014) [Mechanism of urinary output inhibited by Vitamin D analogs in mice]. Zhonghua Yi Xue Za Zhi 94: 780-783.
  150. Butler RJ (2004) Childhood nocturnal enuresis: developing a conceptual framework. Clin Psychol Rev 24: 909-931.
  151. Butler RJ, Holland P (2000) The three systems: a conceptual way of understanding nocturnal enuresis. Scand J Urol Nephrol 34: 270-277.
  152. Wolfish NM, Pivik RT, Busby KA (1997) Elevated sleep arousal thresholds in enuretic boys: clinical implications. Acta Paediatr 86: 381-384.
  153. Bader G, Nevéus T, Kruse S, Sillén U (2002) Sleep of primary enuretic children and controls. Sleep 25: 579-583.
  154. Hunsballe JM (2000) Increased delta component in computerized sleep electroencephalographic analysis suggests abnormally deep sleep in primary monosymptomatic nocturnal enuresis. Scand J Urol Nephrol 34: 294-302.
  155. Yeung CK, Diao M, Sreedhar B (2008) Cortical arousal in children with severe enuresis. N Engl J Med 358: 2414-2415.
  156. Mascarenhas MI, Loureiro HC, Ferreira T, Dias A (2015) Sleep pathology characterization in sickle cell disease: case-control study. Pediatr Pulmonol 50: 396-401.
  157. Daniel LC, Grant M, Kothare SV, Dampier C, Barakat LP (2010) Sleep patterns in pediatric sickle cell disease. Pediatr Blood Cancer 55: 501-507.
Citation: Ahmed FE (2017) Nocturnal Enuresis in Children and Adolescent with Sickle cell Anemia. Med Sur Urol 6:191.

Copyright: © 2017 Ahmed FE. This is an open-access article distributed under the terms of the creative commons attribution license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Top